Latest filing published 01 Sept 2026 for ARS Pharmaceuticals, Inc., €235k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Sarina Tanimoto: trading record in brief
Sarina Tanimoto discloses dealings in ARS Pharmaceuticals, Inc. to SEC (Form 4). We count 5 filings; the first trade dates from 18 August 2026 and the latest from 1 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 1 September 2026: a transaction of €235k, in ARS Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sarina Tanimoto
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 45,388 shares@ US$6.0115CommonSEC144:0001950047-26-008961
- 63,289 shares@ US$5.81620.063% mcap37.3% of flowCommonSEC144:0001950047-26-008852
- 25,000 shares@ US$5.91880.024% mcap23.7% of flowCommonSEC144:0001950047-26-008488
- 25,000 shares@ US$6.44680.026% mcap34.1% of flowCommonSEC144:0001950047-26-008389
- 49,401 shares@ US$6.29930.050% mcap100.0% of flowCommonSEC144:0001950047-26-008362
5 of 5 declarations
